• No results found

GnRH agonist/antagonist

A comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF/ICSI cycles

A comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF/ICSI cycles

... 2). GnRH antagonists investigation coincides with GnRH ...of GnRH antagonists (Ganirelix acetate, Organon, Netherlands) this effect is not seen ...(5). GnRH antagonists prevent premature LH ...

5

GnRH Agonist and GnRH Antagonist in Intracytoplasmic Injection Cycles

GnRH Agonist and GnRH Antagonist in Intracytoplasmic Injection Cycles

... of GnRH agonist and antagonist in a retrospective study of IVF/ICSI carried out in a tertiary teaching hospital from 2003 to ...and antagonist=80) were ...68%. GnRH agonist and ...

5

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

... of GnRH analogues on oocyte morphology and quality remains ...the GnRH-ant group than in the GnRH-a group ...short GnRH-a protocols as com- pared with long-term ...the GnRH ...

10

Effect of Pre-ovulatory Single Dose GnRH Agonist Therapy on IVF Outcome in GnRH Antagonist Cycles; A Prospective Study

Effect of Pre-ovulatory Single Dose GnRH Agonist Therapy on IVF Outcome in GnRH Antagonist Cycles; A Prospective Study

... Therefore, administration of a single-dose GnRH agonist (0.2 mg triptorelin) on the day of hCG trigger in antagonist cycles lead to a small but non-significant improvement in clinical pregnancy and ...

7

Switching from a gonadotropin releasing hormone (GnRH) agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta analysis

Switching from a gonadotropin releasing hormone (GnRH) agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta analysis

... Introduction: We sought to address whether there are clinical responses when patients who are failing gonadotropin-releasing hormone (GnRH) agonist therapy are switched to degarelix. Androgen-deprivation ...

6

Original Article Comparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles

Original Article Comparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles

... the GnRH agonist long protocol and the antago- nist protocol in terms of the duration of ovarian stimulation, number of recombinant FSH (Gonal-F) ampoules used, number of oocytes retrieved, serum levels for ...

8

Comparison between Micro-Dose GnRH Agonist and GnRH Antagonist Protocol in Poor Responders Undergoing Intracytoplasmic Sperm Injection with Embryo Transfer

Comparison between Micro-Dose GnRH Agonist and GnRH Antagonist Protocol in Poor Responders Undergoing Intracytoplasmic Sperm Injection with Embryo Transfer

... microdose GnRH agonist group ...microdose GnRH analogue used in the follicular phase may be explained by a reduction in endothelial nitric oxide synthase levels that may cause improvement in the ...

6

Outcome of cryopreserved-thawed embryo transfer in the GnRH agonist versus antagonist protocol

Outcome of cryopreserved-thawed embryo transfer in the GnRH agonist versus antagonist protocol

... Materials and Methods: The study group included all infertile women who referred to Yazd Research and Clinical Center for Infertility. Overall 20-35 years old women who were candidate for frozen-thawed embryo transfer ...

6

A three-arm randomised controlled trial comparing Gonadotrophin Releasing Hormone (GnRH) agonist long regimen versus GnRH agonist short regimen versus GnRH antagonist regimen in women with a history of poor ovarian response undergoing in vitro fertilisati

A three-arm randomised controlled trial comparing Gonadotrophin Releasing Hormone (GnRH) agonist long regimen versus GnRH agonist short regimen versus GnRH antagonist regimen in women with a history of poor ovarian response undergoing in vitro fertilisation (IVF) treatment: Poor responders intervention trial (PRINT)

... To address the question of their effectiveness, we per- formed a systematic review and meta-analysis. Literature searches were conducted in MEDLINE, EMBASE, the Cochrane Database, National Research Register and ISI ...

9

Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols

Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols

... the agonist group (192 cycles from IVF and 139 cycles from ICSI) while 203 cycles were from the antagonist group (116 cycles from IVF and 87 cycles from ...the agonist and antag- onist groups are ...

7

Switching from a gonadotropin releasing hormone (GnRH) agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta analysis

Switching from a gonadotropin releasing hormone (GnRH) agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta analysis

... Introduction: We sought to address whether there are clinical responses when patients who are failing gonadotropin releasing hormone (GnRH) agonist therapy are switched to degarelix. Androgen-deprivation ...

16

GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)

GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)

... using GnRH-ant it seems, that the differences in reported outcome measurements could be the conse- quence of the large variation of population included in the ...the GnRH-antag regimens as well in ...

8

ART Outcomes in GnRH Antagonist Protocol (Flexible) and Long GnRH Agonist Protocol during Early Follicular Phase in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial

ART Outcomes in GnRH Antagonist Protocol (Flexible) and Long GnRH Agonist Protocol during Early Follicular Phase in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial

... in GnRH antagonist (flexible) was lower than the other groups and statistically was not ...long GnRH ago- nist protocol and GnRH antagonist regimens in PCOS patients undergoing ICSI and ...

7

A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation

A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation

... long GnRH- agonist (GnRHa) suppressive protocol and the multiple- dose GnRH-antagonist (GnRHant) COH ...using GnRH-ant, as opposed to agonists include, mainly, a reduction in the ...

6

What is the value of anti-Müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols?

What is the value of anti-Müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols?

... correlated with the level of ovarian response. Furthermore, the abilities of AMH to successfully predict excessive and poor responses were evaluated. Excessive responses were defined as more than 19 retrieved oocytes or ...

7

GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article

GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article

... only GnRH-a ...with GnRH-a only, in patients with a maximum serum estradiol level of more ...after GnRH-a trigger is unknown, but some evidences indicate the importance of severe steroid support and ...

10

Gonadotropin-Releasing Hormone (GnRH) Agonist Trigger in a GnRH Antagonist Protocol and Severe Ovarian Hyperstimulation Syndrome

Gonadotropin-Releasing Hormone (GnRH) Agonist Trigger in a GnRH Antagonist Protocol and Severe Ovarian Hyperstimulation Syndrome

... 1.2 ng/dL; and LH, 6.7 mUI/mL. The ultrasound examination showed six follicles ≥ 18 mm in diameter, and 17 follicles between 14–18 mm in diameter. Oocyte retrieval was performed 35 hours after the trigger by vaginal ...

5

Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm Injection

Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm Injection

... the GnRH-ant proto- cols in POR and they offered varied ...the GnRH-a protocols when the meta-analysis was applied to the four trials that had used GnRH- ant ...between GnRH-ant and ...

6

GnRH Antagonist Protocol: Is It Effective for Expected Poor Ovarian Responders with Tubal Factor Undergoing IVF?

GnRH Antagonist Protocol: Is It Effective for Expected Poor Ovarian Responders with Tubal Factor Undergoing IVF?

... of GnRH agonists, which can prevent premature luteinization and then significantly reduce the cycle cancellation rate via the nearly complete inhi- bition of spontaneous LH surges (<2%) ...of GnRH ...

7

Switching of GnRH Agent from Agonist  to Antagonist in Patients with Castration Resistant Prostate Cancer

Switching of GnRH Agent from Agonist to Antagonist in Patients with Castration Resistant Prostate Cancer

... (GnRH) agonist to antagonist in patients with castration-resistant prostate cancer ...from GnRH agonist to GnRH ...to GnRH antagonist was ...to GnRH ...

10

Show all 2252 documents...

Related subjects